> BioSpace
> Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer Study
> Published: Sep 27, 2018
> A three-year-old cancer research alliance between U.S. and Cuban scientists is bearing fruit. A Cuban-developed lung cancer treatment combined with Bristol-Myers Squibb’s anti-PDL1 Opdivo shows promise in treating patients who would not likely benefit from immune checkpoint inhibition
>>888
> BioSpace
> Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer Study
> Published: Sep 27, 2018
> A three-year-old cancer research alliance between U.S. and Cuban scientists is bearing fruit. A Cuban-developed lung cancer treatment combined with Bristol-Myers Squibb’s anti-PDL1 Opdivo shows promise in treating patients who would not likely benefit from immune checkpoint inhibition
【Google検索のまま】
BioSpace
Just-Announced米国とキューバBiopharma Venture、肺癌研究で果実を見る
公開日：2018年9月27日
米国とキューバの科学者の間に3年前のがん研究連合が成果を上げています。 Bristol-Myers Squibbの抗PDL1 Opdivoと組み合わせた、キューバで開発された肺がん治療は、免疫チェックポイント阻害から恩恵を受ける可能性の低い患者の治療に有望である。